Effects of Gabapentin and Amitryptiline for pain management in Rheumatoid Arthritis patients.
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor
- Registration Number
- CTRI/2019/04/018467
- Lead Sponsor
- ESI Institute of Pain Management
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
2.Seropositivityie. rheumatoid factor positive
3.On DMARDs[single or combination] for more than 3 months
4.Pain Score ie.NRS more than 4/10
5.Presence of neuropathic components like complaints of burning ,tingling nature of pain,
numbness, hyperaesthesia, distant pain, pain experienced in areas outside the affected joints etc.
Exclusion Criteria
1.Acute flare
2.Seronegativity
3.History of mental illness like MDP ,Schizophrenia or other psychoses
4.History of IHD, Ventricular conduction defects, Stroke, Liver disease, seizure disorders
5.Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method